Congestive heart failure pharmacotherapy: Difference between revisions
Jump to navigation
Jump to search
Tarek Nafee (talk | contribs) (/* Congestive heart failure treatment summary based on 2013 ACCF/AHA Guideline{{cite journal |vauthors=Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi...) |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Congestive heart failure}} | {{Congestive heart failure}} | ||
{{CMG}};{{AE}}{{MehdiP}} | {{CMG}};{{AE}}{{MehdiP}} | ||
== Overview == | |||
The following table summarized the stepwise treatment for heart failure. | |||
==Congestive heart failure treatment summary based on 2013 ACCF/AHA Guideline<ref name="pmid23741057">{{cite journal |vauthors=Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL |title=2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines |journal=Circulation |volume=128 |issue=16 |pages=1810–52 |year=2013 |pmid=23741057 |doi=10.1161/CIR.0b013e31829e8807 |url=}}</ref>== | ==Congestive heart failure treatment summary based on 2013 ACCF/AHA Guideline<ref name="pmid23741057">{{cite journal |vauthors=Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL |title=2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines |journal=Circulation |volume=128 |issue=16 |pages=1810–52 |year=2013 |pmid=23741057 |doi=10.1161/CIR.0b013e31829e8807 |url=}}</ref>== | ||
| Line 30: | Line 34: | ||
* [[Beta blockers]] | * [[Beta blockers]] | ||
* [[Spironolactone|Aldostrone antagonists]] | * [[Spironolactone|Aldostrone antagonists]] | ||
* | * Combination of [[hydralazine]] and a [[nitrate]] | ||
* [[Digoxin]] | * [[Digoxin]] | ||
Revision as of 15:36, 28 October 2016
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]
Overview
The following table summarized the stepwise treatment for heart failure.
Congestive heart failure treatment summary based on 2013 ACCF/AHA Guideline[1]
| Acute Decompensated | Chronic | |
|---|---|---|
| HFpEF | ||
| HFrEF |
|
References
- ↑ Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL (2013). "2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines". Circulation. 128 (16): 1810–52. doi:10.1161/CIR.0b013e31829e8807. PMID 23741057.